MarcioAFagundesMD

Overview of Dr. Fagundes

Marcio Fagundes, M.D., is the Medical Director of the Radiation Oncology Department of the Miami Cancer Institute at Baptist Health South Florida. Dr. Fagundes attended medical school at Universidad Federal do Rio Grande do Sul in Brazil. He completed internship at Jackson Memorial Hospital, residency in radiation oncology at Sylvester Comprehensive Cancer Center and fellowship in radiation oncology (proton therapy) at Massachusetts General Hospital, Harvard dedicated to proton therapy training. Following fellowship, Dr. Fagundes served as assistant professor of radiation oncology at TUFTS University School of Medicine in Boston, during which time intensity modulated radiotherapy was being developed into clinical use. Dr. Fagundes worked for several years in Brazil where he introduced several advances in radiotherapy such as radiosurgery, high dose rate brachytherapy for gynecologic and breast malignancies, as well as low dose rate permanent implant brachytherapy for prostate cancer. Dr. Fagundes pioneered the utilization of rectal spacer gel known as SpaceOAR to displace the rectum away from the prostate being the first physician to utilize this method with proton therapy in the world on April 6th 2015, following the FDA release of SpaceOAR rectal spacer. He has treated well over 300 prostate cancer patients with rectal spacer and proton therapy exceptional outcomes presented in multiple worldwide medical meetings such as PTCOG – Proton Therapy Collaborative Group. Dr. Fagundes is a mentor and trains physicians who are in the process of adopting these new techniques, including various forms of advanced proton therapy.